Human Longevity Launches $599 Whole Genome Sequencing with AI Insights

May 11, 2026
Human Longevity, Inc. has introduced a clinical grade whole genome sequencing report priced at $599, offering AI supported insights for disease prevention and personalized health management.

Human Longevity, Inc. announced in a press release the launch of its Clinical Grade Whole Genome Sequencing Report, available for $599. The new service combines genomic sequencing with AI supported analysis to help identify inherited disease risks, carrier status, pharmacogenomic factors, and longevity related traits.

The offering honors the legacy of Dr. J. Craig Venter, whose work on decoding the first human genome laid the foundation for modern genomics. Human Longevity stated that over the past decade it has invested more than $600 million in building a longitudinal health dataset covering more than 10,000 individuals. This data has been used to train proprietary AI models focused on chronic diseases such as cardiovascular disease, cancer, and dementia.

The company said the new report aims to make clinical grade genome sequencing broadly accessible to the public. The service is available nationwide through Human Longevity’s website.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

05/11
Zifo Expands CMC Data Automation Partnerships with Top Biopharma Companies
05/11
Stowers Institute and Helmholtz Munich Develop RegVelo AI to Predict Cell Fate
05/11
Astrana Health and Physician Association of California Partner to Support Independent Primary Care
05/08
Zifo Introduces AI Authoring Tool for Regulatory Submissions
05/08
Basata Raises $21 Million Series A to Expand AI Healthcare Operations Platform

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like